Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Brisson

Showing results (41-50 of 145) with videos related to

Pageof 15
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 9, 2014
Changing inequalities in cervical cancer: modeling the impact of vaccine uptake, vaccine herd effects, and cervical cancer screening in the post-vaccination eraTalía Malagón, Mélanie Drolet, Marie-Claude Boily, et al.
Analytical Chemistry|September 11, 2003
High-performance liquid chromatography-atmospheric pressure photoionization/tandem mass spectrometric analysis for small molecules in plasmaYunsheng Hsieh, Kara Merkle, Ganfeng Wang, et al.
Vaccine|June 15, 2007
The potential cost-effectiveness of prophylactic human papillomavirus vaccines in CanadaMarc Brisson, Nicolas Van de Velde, Philippe De Wals, et al.
Plos One|October 1, 2016
Mathematical Modeling of the Transmission Dynamics of Clostridium difficile Infection and Colonization in Healthcare Settings: A Systematic ReviewGuillaume Gingras, Marie-Hélène Guertin, Jean-François Laprise, et al.
Clinical Therapeutics|August 24, 2010
Proceedings of the Modeling Evidence in HPV Pre-Conference Workshop in Malmö, Sweden, May 9-10, 2009Benjamin M Craig, Marc Brisson, Harrell Chesson, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 16, 2003
Simultaneous fast HPLC-MS/MS analysis of drug candidates and hydroxyl metabolites in plasmaYunsheng Hsieh, Jean-Marc Brisson, Ganfeng Wang, et al.
Pharmacoeconomics|April 12, 2006
A cost-utility analysis of losartan versus atenolol in the treatment of hypertension with left ventricular hypertrophyAslam H Anis, Huiying Sun, Sonia Singh, et al.
Annals of Internal Medicine|November 25, 2024
Cost-Effectiveness of Extending Human Papillomavirus Vaccination to Population Subgroups Older Than 26 Years Who Are at Higher Risk for Human Papillomavirus Infection in the United StatesJean-François Laprise, Harrell W Chesson, Lauri E Markowitz, et al.
Vaccine|March 9, 2016
Can high overall human papillomavirus vaccination coverage hide sociodemographic inequalities? An ecological analysis in CanadaMelanie Drolet, Shelley L Deeks, Erich Kliewer, et al.
Annals of Internal Medicine|November 17, 2025
Cost-Effectiveness of Extending Human Papillomavirus Vaccination to Population Subgroups Older Than 26 Years Who Are at Higher Risk for Human Papillomavirus Infection in the United StatesJean-François Laprise, Harrell W Chesson, Lauri E Markowitz, et al.
Pageof 15

Showing results (41-50 of 145) with videos related to

Sort By:
Pageof 15
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 9, 2014
Changing inequalities in cervical cancer: modeling the impact of vaccine uptake, vaccine herd effects, and cervical cancer screening in the post-vaccination eraTalía Malagón, Mélanie Drolet, Marie-Claude Boily, et al.
Analytical Chemistry|September 11, 2003
High-performance liquid chromatography-atmospheric pressure photoionization/tandem mass spectrometric analysis for small molecules in plasmaYunsheng Hsieh, Kara Merkle, Ganfeng Wang, et al.
Vaccine|June 15, 2007
The potential cost-effectiveness of prophylactic human papillomavirus vaccines in CanadaMarc Brisson, Nicolas Van de Velde, Philippe De Wals, et al.
Plos One|October 1, 2016
Mathematical Modeling of the Transmission Dynamics of Clostridium difficile Infection and Colonization in Healthcare Settings: A Systematic ReviewGuillaume Gingras, Marie-Hélène Guertin, Jean-François Laprise, et al.
Clinical Therapeutics|August 24, 2010
Proceedings of the Modeling Evidence in HPV Pre-Conference Workshop in Malmö, Sweden, May 9-10, 2009Benjamin M Craig, Marc Brisson, Harrell Chesson, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 16, 2003
Simultaneous fast HPLC-MS/MS analysis of drug candidates and hydroxyl metabolites in plasmaYunsheng Hsieh, Jean-Marc Brisson, Ganfeng Wang, et al.
Pharmacoeconomics|April 12, 2006
A cost-utility analysis of losartan versus atenolol in the treatment of hypertension with left ventricular hypertrophyAslam H Anis, Huiying Sun, Sonia Singh, et al.
Annals of Internal Medicine|November 25, 2024
Cost-Effectiveness of Extending Human Papillomavirus Vaccination to Population Subgroups Older Than 26 Years Who Are at Higher Risk for Human Papillomavirus Infection in the United StatesJean-François Laprise, Harrell W Chesson, Lauri E Markowitz, et al.
Vaccine|March 9, 2016
Can high overall human papillomavirus vaccination coverage hide sociodemographic inequalities? An ecological analysis in CanadaMelanie Drolet, Shelley L Deeks, Erich Kliewer, et al.
Annals of Internal Medicine|November 17, 2025
Cost-Effectiveness of Extending Human Papillomavirus Vaccination to Population Subgroups Older Than 26 Years Who Are at Higher Risk for Human Papillomavirus Infection in the United StatesJean-François Laprise, Harrell W Chesson, Lauri E Markowitz, et al.
Pageof 15